Your session is about to expire
← Back to Search
Stereotactic Radiation for Pancreatic Cancer
Study Summary
This trial is testing a new radiation therapy treatment for pancreatic or periampullary cancer that has come back or not responded to other treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am able to care for myself but may not be able to do active work.My cancer is confirmed as pancreatic or close to the pancreas.I have had standard pancreatic cancer treatment, with or without radiation.My pancreatic tumor is smaller than 8 cm.I am a woman who is not post-menopausal and I have a positive pregnancy test.I can understand and agree to the study's requirements.I will receive SBRT treatment exclusively at Johns Hopkins Hospital.I do not have any untreated or uncontrolled illnesses.My blood tests show my organs and bone marrow are functioning well.I am 18 years old or older.I have no other cancer except possibly melanoma.I am an adult.My health allows me to be mostly active.My cancer has spread extensively to other parts of my body.
- Group 1: RT naive
- Group 2: Previous RT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment have an age limit of 35 years or older?
"Eligibility requirements state that individuals between 18 and 100 years old may apply to be a part of this study. There are 13 other clinical trials for children under 18 and 1130 for seniors above the age of 65."
Has the Food and Drug Administration previously approved this type of radiation therapy?
"While there is some evidence of safety, as this is a phase 2 trial, Power rates the Previous RT's safety at a 2."
Are there any vacancies in this clinical trial for new participants?
"This particular clinical trial, despite having been updated as recently as March 9th of this year, is not currently looking for new recruits. However, there are over one thousand other trials that are actively searching for patients right now."
To which patients does this clinical trial apply?
"Candidates for this clinical trial must have periampullary adenocarcinoma, be of age (between 18 and 100 years old), and there are only 120 positions available in total."
Share this study with friends
Copy Link
Messenger